2010
DOI: 10.2217/ica.10.51
|View full text |Cite
|
Sign up to set email alerts
|

AngioSculpt®scoring balloon catheter: an atherotomy device for coronary and peripheral interventions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(5 citation statements)
references
References 43 publications
(24 reference statements)
0
5
0
Order By: Relevance
“…[41,42] In a feasibility trial, the AngioSculpt balloon was used for the treatment of de novo lesions prior to BMS implantation and showed very high procedural success and a target lesion revascularisation rate of 10% at 6 months. [43]…”
Section: Percutaneous Coronary Intervention Of Complex Calcified Coromentioning
confidence: 99%
“…[41,42] In a feasibility trial, the AngioSculpt balloon was used for the treatment of de novo lesions prior to BMS implantation and showed very high procedural success and a target lesion revascularisation rate of 10% at 6 months. [43]…”
Section: Percutaneous Coronary Intervention Of Complex Calcified Coromentioning
confidence: 99%
“…In addition, they reduce elastic recoil, prevent uncontrolled stripping, and are used in stented lesions that restenosis after dilatation 65 , 66 . The largest published registry study showed that the largest registry experience of Angio-Sculpt for the treatment of 745 lesions with at least moderate calcification reported a 30-day major adverse cardiac event (MACE) of 2.9% and a procedure success rate of 97.9% 67 . Their use is limited to lesions with severe calcification and those that cannot be traversed by a standard pre-dilated balloon.…”
Section: Interventional Treatmentmentioning
confidence: 99%
“…ELCA consists of a 0.9-mm-diameter catheter passed through a 0.014-inch guidewire, with the wire placed distal to the lesion, and then the laser is moved until it is in direct contact with the lesion, and, for maximal effect, the laser is advanced at a rate of 1 mm/s. ECLA is indicated in cases where a balloon cannot be dilated lesions, as well as insufficient stent dilation and proximal chronic total occlusion lesions 67 . Saline is less able to absorb energy than blood or contrast media.…”
Section: Interventional Treatmentmentioning
confidence: 99%
See 1 more Smart Citation
“…It is available also in a drug-coated version (AngioSculpt X) [ 57 , 58 ]. A very high procedural success and target lesion revascularisation rate of 10% at 6 months was shown in a feasibility trial to treat de novo lesions prior to bare-metal stent implantation [ 59 ]. In an observational study, these results were confirmed in 37 patients who had been treated with AngioSculpt prior to the implantation of a stent against 145 patients receiving direct stenting and 117 patients having traditional plain old balloon angioplasty before a stent was implanted.…”
Section: Scoring Balloonsmentioning
confidence: 99%